SCHEMBL247973

SCHEMBL247973

Pn1nnc2ccccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 9/20 0.56
MAPT P10636 2/20 0.56
POLB P06746 1/20 0.56
MAPK1 P28482 1/20 0.56
ATM Q13315 1/20 0.56
KEAP1 Q14145 1/20 0.56
ALDH1A1 P00352 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
THPO P40225 1/20 0.56
CYP4Z1 Q86W10 1/20 0.56
DGAT1 O75907 1/20 0.50
GRM2 Q14416 1/20 0.47
RAB9A P51151 2/20 0.46
KCNMA1 Q12791 1/20 0.46
TSHR P16473 2/20 0.44
MGAM O43451 1/20 0.44
F2 P00734 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3745056 0.76 SLC9A1 (0.56) SLC9A1MAPTPOLBMAPK1ATM
SCHEMBL3072391 0.75 SLC9A1 (0.60) SLC9A1MAPTPOLBMAPK1ATM
SCHEMBL9172879 0.74 SLC9A1 (0.54) SLC9A1MAPTPOLBMAPK1ATM
SCHEMBL3672275 0.71 POLB (1.00) SLC9A1MAPTPOLBMAPK1ATM
SCHEMBL4634282 0.71 SLC9A1 (0.56) SLC9A1MAPTPOLBMAPK1ATM
SCHEMBL18372356 0.71 SLC9A1 (0.56) SLC9A1MAPTPOLBMAPK1ATM
SCHEMBL11872036 0.71 SLC9A1 (0.56) SLC9A1MAPTPOLBMAPK1ATM
SCHEMBL15548600 0.71 SLC9A1 (0.56) SLC9A1MAPTPOLBMAPK1ATM
SCHEMBL1012471 0.71 POLB (1.00) SLC9A1MAPTPOLBMAPK1ATM
SCHEMBL422528 0.71 POLB (0.61) SLC9A1MAPTPOLBMAPK1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140350301-A1 NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR ACTAVIS GROUP PTC EHF (IS) 2014-11-27 US claimed
US-20130165696-A1 NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR ACTAVIS GROUP PTC EHF (IS) 2013-06-27 US claimed
EP-2588441-A2 NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR Actavis Group Ptc Ehf (IS) 2013-05-08 EP claimed
CN-103003231-A Novel method for preparing phenylcyclopropylamine derivatives and use thereof for preparing ticagrelor ACTAVIS GROUP PTC EHF 2013-03-27 CN claimed
WO-2012001531-A2 NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR ACTAVIS GROUP PTC EHF (IS) 2012-01-05 WO claimed
WO-2024138147-A1 HYDROGEN ENERGY STORAGE VIA PLASMA-BASED TECHNOLOGY THE TEXAS A&M UNIVERSITY SYSTEM (US) 2024-06-27 WO disclosed
WO-2024011174-A9 SYSTEMS FOR ELECTROENCEPHALOGRAPHY AND METHODS FOR USE AND MANUFACTURE OF THE SAME THE GENERAL HOSPITAL CORPORATION (US) 2024-05-23 WO disclosed
WO-2024052363-A1 POLYMERIZABLE LIQUID CRYSTAL MATERIAL AND POLYMERIZED LIQUID CRYSTAL FILM MERCK PATENT GMBH (DE) 2024-03-14 WO disclosed
WO-2023119099-A1 DEVOLATILIZATION OF ETHYLENE/α-OLEFIN COPOLYMER PELLETS NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2023-06-29 WO disclosed
US-11577241-B2 Acoustofluidic systems including acoustic wave generators for manipulating fluids, droplets, and micro/nano objects within a fluid suspension and related methods DUKE UNIVERSITY (US) 2023-02-14 US disclosed
US-20220392134-A1 Method for Simulating Combustion in Digital Imagery with Equilibrium and Non-Equilibrium Conditions UNITY TECHNOLOGIES SF 2022-12-08 US disclosed
US-20210145608-A1 Quantitative Design And Manufacturing Framework For A Biomechanical Interface Contacting A Biological Body Segment UNITED STATES GOVERNMENT 2021-05-20 US disclosed
US-20140058058-A1 MONOMERS AND POLYMERS FOR FUNCTIONAL POLYCARBONATES AND POLY(ESTER-CARBONATES) AND PEG-CO-POLYCARBONATE HYDROGELS UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL (US) 2014-02-27 US disclosed
US-20130165696-A1 NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR ACTAVIS GROUP PTC EHF (IS) 2013-06-27 US disclosed
EP-2588441-A2 NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR Actavis Group Ptc Ehf (IS) 2013-05-08 EP disclosed
CN-103003231-A Novel method for preparing phenylcyclopropylamine derivatives and use thereof for preparing ticagrelor ACTAVIS GROUP PTC EHF 2013-03-27 CN disclosed
US-20130026044-A1 CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-01-31 US disclosed
US-20130026044-A1 CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-01-31 US disclosed
EP-2551722-A1 Chemically amplified positive resist composition and patterning process Shin-Etsu Chemical Co., Ltd. (JP) 2013-01-30 EP disclosed
WO-2012001531-A2 NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR ACTAVIS GROUP PTC EHF (IS) 2012-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140058058-A1 MONOMERS AND POLYMERS FOR FUNCTIONAL POLYCARBONATES AND POLY(ESTER-CARBONATES) AND PEG-CO-POLYCARBONATE HYDROGELS PUF60, CCNC, CALCOCO2 SLC9A1 3984/4885MAPT 2329/4885POLB 3297/4885
US-20140350301-A1 NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR THPO, P2RY4, TBXA2R SLC9A1 2532/4885MAPT 3525/4885POLB 3411/4885
US-20130165696-A1 NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR THPO, P2RY4, TBXA2R SLC9A1 2532/4885MAPT 3525/4885POLB 3411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.